基于纳米载体的免疫疗法用于病毒性疾病
Dan Liu1,2, Te Zhao1,2, Yi Li2,3
1School of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China.
International journal of pharmaceutics: X
|October 23, 2025
概括
新型纳米载体技术增强了病毒性疾病的免疫疗法,提高了稳定性和向性,以克服局限性并提高对全球健康威胁的治疗效率.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 纳米技术纳米技术
背景情况:
- 病毒性疾病对全球公共卫生和经济构成重大挑战.
- 目前针对病毒感染的免疫疗法面临着不稳定性,准性和毒性等局限性.
- 纳米载体通过保护治疗药物,实现向输送和控制释放来提供解决方案.
研究的目的:
- 审查病毒性疾病中免疫治疗的分类和应用.
- 探索免疫疗法与纳米载体的组合,以改善病毒性疾病的治疗.
- 讨论基于纳米载体的免疫疗法的挑战和未来前景.
主要方法:
- 关于免疫治疗和纳米载体在病毒学中的应用的文献综述.
- 对纳米载体特征的分析与克服免疫疗法的局限性有关.
- 综合关于联合免疫疗法和纳米载体策略的当前研究.
主要成果:
- 纳米载体保护治疗剂免受降解,并实现有针对性的输送.
- 从纳米载体中控制释放保持最佳的治疗度.
- 将免疫疗法与纳米载体结合起来,有可能显著提高治疗疗效.
结论:
- 纳米载体介导免疫疗法是解决病毒感染传统免疫疗法的局限性的有希望的策略.
- 这种方法有可能改善对病毒性疾病的预防和治疗干预措施.
- 需要进一步的研究来克服挑战,并充分实现临床前景.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
1.3K
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.7K
相关概念视频
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
Immune Response Against Viral Pathogens
1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Cancer Vaccines
952
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
Cell-mediated Immune Responses
83.4K
Overview
83.4K
